tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

OptimizeRx raises FY25 revenue view to $105M-$109M from $104M-$108M

Consensus $106.92M. The company said, “The Company is increasing its fiscal year 2025 guidance and expects revenue to be between $105 million and $109 million with Adjusted EBITDA to be between $16 million and $19 million.”

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1